Back
ESC Premium Access

Trends in major bleeding events in patients with acute coronary syndrome.

Session: Acute Coronary Syndromes ePosters
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor A. Cordero (Sant Joan d'Alacant, ES)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

0

About the speaker

Doctor Alberto Cordero

UNIVERSITY HOSPITAL SAN JUAN DE ALICANTE, Sant Joan d'Alacant (Spain)
2 presentations
0 follower

205 more presentations in this session

Optimal timing of intervention in NSTE-ACS without pre-treatment

Speaker: Doctor I. Almeida (Barreiro, PT)

Access
Abstract
Slides
0
Thumbnail

Antithrombotic strategy in patients with atrial fibrillation and acute coronary syndrome

Speaker: Doctor I. Almeida (Barreiro, PT)

Access
Abstract
Slides
0
Thumbnail

Drug-eluting balloon catheters in the treatment of left main coronary artery bifurcation lesions: 4-years follow-up

Speaker: Associate Professor D. Maximkin (Moscow, RU)

Access
Abstract
Slides
0
Thumbnail

Clinical outcomes by angiographic type of spontaneous coronary artery dissection

Speaker: Doctor R. Mori Junco (Madrid, ES)

Access
Abstract
Slides
0
Thumbnail

Clinical impact of CREDO-kyoto risk score on in-hospital bleeding in patients with acute coronary syndrome

Speaker: Doctor Y. Minematsu (Saga, JP)

Access
Abstract
Slides
0
Thumbnail

Access the full session

Acute Coronary Syndromes ePosters

Speakers: Doctor A. Cordero, Doctor I. Almeida, Doctor I. Almeida, Associate Professor D. Maximkin, Doctor R. Mori Junco...
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

SYNTAX II trial: five year follow-up

29 August 2021

ESC Premium Access

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial - Chat Moderator.

27 August 2021

ESC Premium Access

Clinical benefit of direct oral anticoagulants vs. vitamin-K antagonist in octogenarians with atrial fibrillation

27 August 2021

ESC 365 is supported by

logo Novo Nordisk